Taken together, these findings indicate that the microprotein TPM3P9 modulates the splicing of TCF7L2 RNA to generate the oncogenic splice variant TCF7L2-L in ccRCC cells. This evidence concerns the gene TPM3P9 and nonpapillary renal cell carcinoma.